The North America esophageal stents market is expected to experience steady growth through 2034, driven by the increasing prevalence of esophageal cancer, gastroesophageal disorders, and benign esophageal strictures across the region. Rising demand for minimally invasive procedures, growing adoption of self-expanding metal stents (SEMS), and continuous advancements in stent design and...